Search results
AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
AstraZeneca's primary listing is on the London Stock Exchange and is a constituent of the FTSE 100 Index; it also has a secondary listing on the Nasdaq Stockholm. AstraZeneca has one of the highest market capitalisations of pharmaceutical companies worldwide.
At AstraZeneca we’re united by our desire to push the boundaries of science to deliver life-changing medicines. We know it’s how we will continue to transform the lives of millions of patients around the world while delivering value to our employees, our communities, and the environment.
Jul 1, 2024 · AstraZeneca’s Marketing Authorisation Application (MAA) for sipavibart has been accepted under an accelerated assessment procedure by the European Medicines Agency (EMA), for the pre-exposure prophylaxis (prevention) of COVID-19 in immunocompromised patients. Sipavibart is an investigational long-acting antibody designed to provide COVID-19 ...
Overview. AstraZeneca completes 45 years of its presence in India in the year 2024. As pioneers in science, we are deeply invested in transforming patient outcomes by bringing novel therapies closer for patients and working hand in hand with the healthcare ecosystem to accelerate health equity in the country. At AstraZeneca India, we are united ...
Jul 4, 2024 · AstraZeneca: With the highly skilled roles to be brought in by 2025, the expanded GITC will propel the company's vision to leverage technologies such as enterprise platforms, artificial ...
Our commitment. We are committed to developing and delivering transformative vaccines and antibodies, providing long-lasting immunity for millions of people, where the burden of disease is greatest.
Jul 4, 2024 · AstraZeneca India Private Limited (AZIPL), the global capability centre (GCC) of British-Swedish drugmaker AstraZeneca, announced an investment of Rs 250 crore ($30 million) to expand its Global Innovation and Technology Centre (GITC) in Chennai. The expansion includes adding close to 1,300 job roles focused on driving innovation, enhancing efficiency, and streamlining operations across the company globally.
AstraZeneca India is a dedicated biopharmaceutical company discovering and developing innovative medicines for life-changing diseases. Learn more about our India chapter and our global edge, here.
Introducing AstraZeneca's Board of Directors, Senior Executives and Lead Scientists. Find information on each individual membership of the leadership team. Skip to content
